PMID:
Clin Case Rep. 2020 Apr ;8(4):739-744. Epub 2020 Feb 25. PMID: 32274049
Abstract Title:
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.
Abstract:
Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
Health Time 